Abstract

In this paper, we quantify the joint acoustic emissions (JAEs) from the knees of children with juvenile idiopathic arthritis (JIA) and support their use as a novel biomarker of the disease. JIA is the most common rheumatic disease of childhood; it has a highly variable presentation, and few reliable biomarkers which makes diagnosis and personalization of care difficult. The knee is the most commonly affected joint with hallmark synovitis and inflammation that can extend to damage the underlying cartilage and bone. During movement of the knee, internal friction creates JAEs that can be non-invasively measured. We hypothesize that these JAEs contain clinically relevant information that could be used for the diagnosis and personalization of treatment of JIA. In this study, we record and compare the JAEs from 25 patients with JIA−10 of whom were recorded a second time 3–6 months later—and 18 healthy age- and sex-matched controls. We compute signal features from each of those record cycles of flexion/extension and train a logistic regression classification model. The model classified each cycle as having JIA or being healthy with 84.4% accuracy using leave-one-subject-out cross validation (LOSO-CV). When assessing the full JAE recording of a subject (which contained at least 8 cycles of flexion/extension), a majority vote of the cycle labels accurately classified the subjects as having JIA or being healthy 100% of the time. Using the output probabilities of a JIA class as a basis for a joint health score and test it on the follow-up patient recordings. In all 10 of our 6-week follow-up recordings, the score accurately tracked with successful treatment of the condition. Our proposed JAE-based classification model of JIA presents a compelling case for incorporating this novel joint health assessment technique into the clinical work-up and monitoring of JIA.

Highlights

  • Juvenile idiopathic arthritis (JIA) describes a heterogeneous group of arthritides that present in children

  • We explore the potential of using joint acoustic emissions (JAEs) analysis to diagnose and longitudinally track JIA

  • The JAEs were recorded from the knees of two groups of children

Read more

Summary

INTRODUCTION

Juvenile idiopathic arthritis (JIA) describes a heterogeneous group of arthritides that present in children. JIA encompasses all forms of arthritis that begin before a patient is 16 years old, lasts for at least 6 weeks, and are of an unknown origin It is a leading cause of disability and the most common chronic rheumatic disease of childhood with a prevalence of 150 cases per 100,000 [1]. The development of such a biomarker could allow for more effective translation of the many genetic and immunological mechanistic studies of the disease to further improve clinical outcomes This biomarker would be readily measurable with affordable technologies, so that JIA could be diagnosed and monitored by non-specialist healthcare workers. To assess the effectiveness of JAEs for tracking therapeutic efficacy and changes in disease status, we recorded the JAEs from the children with JIA 6 weeks after successful treatment. We assess the importance of each signal feature in the algorithm as well as the accuracy and generalizability of the model using leave-one-subject-out cross-validation (LOSO-CV)

RESULTS
Limitations and Steps to Clinical Adoption
MATERIALS AND METHODS
ETHICS STATEMENT

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.